Verify any claim · lenz.io
Claim analyzed
Health“In New Zealand, funded sumatriptan and funded rizatriptan are available at the standard prescription co-payment of about NZ$5 for people with a Community Services Card.”
Submitted by Witty Bear 3164
The conclusion
Open in workbench →The evidence does not support this statement. Official New Zealand sources indicate Community Services Card holders generally pay no co-payment for fully subsidised prescriptions from publicly funded or approved providers, not “about NZ$5.” In addition, the materials provided directly support funded sumatriptan but do not directly verify funded rizatriptan.
Caveats
- The NZ$5 figure describes the general co-payment framework, but Community Services Card holders are commonly exempt and may pay NZ$0 for fully subsidised items.
- The evidence set does not directly confirm rizatriptan's funded status, so that part of the claim is unsupported.
- Prescription charges can vary by provider type and whether the medicine is fully subsidised, so broad pricing claims need those conditions stated clearly.
This analysis is for informational purposes only and does not constitute health or medical advice, diagnosis, or treatment. Always consult a qualified healthcare professional before making health-related decisions.
Get notified if new evidence updates this analysis
Create a free account to track this claim.
Sources
Sources used in the analysis
Pharmac’s funded medicine list shows **sumatriptan** as a subsidised medicine in New Zealand. The schedule entry indicates the medicine is funded, with patient charges determined by the standard community pharmaceutical co-payment rules rather than a higher private price.
The Community Services Card lowers the usual prescription co-payment. For cardholders, the maximum co-payment for subsidised medicines is **NZ$5** per prescription item.
From 1 July 2024 prescriptions from approved providers may include a maximum of $5 co-payment per item. You may be exempt from this charge depending on your age and whether you hold a Community Services Card (CSC) or Prescription Subsidy Card (PSC). Prescriptions from specialists and non-publicly funded prescribers, such as dentists, still have a $15 charge.
People need to pay the standard $5 prescription charge, with exemptions for people: aged 13 years or under; holding a Community Services Card (CSC), or a dependent child of a CSC holder; aged 65 years or over; holding a Prescription Subsidy Card (PSC). This applies to every medicine on new prescriptions.
The Ministry of Health explains that people with a Community Services Card pay the standard subsidised prescription charge, which is lower than the general public charge. This is the mechanism by which funded medicines such as triptans are dispensed at the cardholder rate.
The Pharmac schedule and subsidy framework show that funded medicines are dispensed with a patient co-payment, and the Community Services Card sets that co-payment at the cardholder rate. This supports the claim that funded triptans can be obtained for about NZ$5 by eligible patients.
The Community Services Card can reduce the cost of: visits to your regular general practice for cardholders and their dependants; visits to a general practice you are not enrolled with; **prescription fees**; fees for after hours general practice visits; glasses for tamariki under 16.
The Community Services Card can help you with the costs of health care and public transport. This means you could pay less on some health services, such as: subsidised **prescriptions – these are free if you have a Community Services Card**; visits to a health practitioner (for example, a doctor or nurse).
"Many people will need to pay a **$5 co-payment** to collect their medicine from the pharmacy. Some people do not have to pay the co-payment." "You do not need to pay a co-payment after the first dispensing from your prescription, when you pick up a repeat." This NZ government medicine funding page confirms that the usual co-payment for funded medicines is NZ$5 per item at the pharmacy, with some groups exempt.
Prescriptions: $5 per item (standard co-payment, reinstated 1 July 2024). Free for under-14s, those 65+, and Community Services Card holders. After 20 paid items in a year, the rest are free (Prescription Subsidy Card). Verified June 2026.
These charges reduce to $5 if: a person has a High Use Health Card; a Community Services Card; the prescription is for an oral contraceptive.
In Aotearoa New Zealand, unless you're under 14 years of age or 65 years and over, most people will have to pay **$5 for each medicine prescribed** that is subsidised or partially subsidised by the government. Medicines that are fully subsidised (funded) still require you to pay a prescription charge (also known as a prescription co-payment) unless you: are under 14 years of age; are 65 years of age or over; have a Prescription Subsidy Card; **have a Community Services Card and the medicine is prescribed by your GP or a healthcare provider working in a public hospital.** Having a CSC will make all subsidised medicines free if the prescription is written by your GP or a healthcare provider in a public hospital.
In New Zealand, co-payments are low (**$5 per item with an annual ceiling of 20 items per family**, after which co-payments are waived) but there are no exemptions for people with low income or severe chronic disease. On 1 February each year co-payments commence, and after an individual or family is dispensed 20 items, copayments are waived.
Community Services Card holders are exempt from the $5 co-pay from 1 July. Use a prescription code suffixed with 1 to indicate this. A1, J1, Z1, ... A1 for an adult with a Community Services Card.
Official New Zealand dispensing guidance notes that funded medicines are subject to the usual prescription fee schedule, and Community Services Card eligibility reduces the amount paid by the patient at the pharmacy.
The Community Services Card can reduce the cost of: visits to a health practitioner (eg, a doctor or nurse) if you're enrolled at their practice; ACC visits to a general practice if you're injured; **subsidised prescriptions – these are free if you have a Community Services Card**; partially or unsubsidised prescriptions, or prescriptions from private specialists; fares for public transport including trains, buses and some ferries.
If you're eligible for the card, you'll pay less for some health services for yourself or any dependent children in your care. The card can reduce the cost of: **prescription fees**, visits to a health practitioner, after-hours doctor visits, and glasses for children.
Get free prescriptions in New Zealand by using a Community Services Card. **The standard $5 prescription co-payment has returned.** The standard $5 prescription co-payment is back as of 1 July 2024. From 1 July 2024 your pharmacy may start charging you the standard $5 prescription co-payment per item. For those on regular medicines it can be a big cost saver, as **Community Service Card holders are exempt from the standard $5 prescription charge – as are their dependent children under 18 years of age.**
From 1 July 2024, prescriptions issued by approved providers may attract a co-payment of no more than NZ$5 per item. Exemptions from this charge exist depending on age and whether the patient holds a Community Services Card or Prescription Subsidy Card.
A Community Services Card can reduce healthcare costs. Anyone on a low income who is aged 16 or over, a NZ citizen or permanent resident can apply. **A Community Services Card reduces the cost of full-priced prescriptions** and visits to health practitioners.
For drugs prescribed by GPs and private specialists, **copayments of NZD 5.00 are required for the first 20 prescriptions per family per year, after which there are no copayments.** Community Services Card holders do not have to pay this copayment. Low-income people can also lower their copayments by seeking a community services card.
From 1 July 2024 the **$5 co-payment for fully subsidised prescription items** from publicly funded health providers (including public specialists) will return. If you’re 65 years or older, or **have a Community Services Card, fully subsidised prescription items from publicly funded health providers will remain free.** They will also remain free for those under 14 and 14–17-year-olds who are dependents of Community Services Card holders.
This co-payment is also waived for patients under 14 and 65 years and older and some patients with a Community Services Card.
NZ$5 if a person has a High Use Health Card, a Community Services Card or if the prescription is for an oral contraceptive. Once people living with dementia ...
What do you think of the claim?
Your challenge will appear immediately.
Challenge submitted!
For developers
This same pipeline is available via API.
Verify your AI's output programmatically.
/extract pulls claims from text ·
/verify returns sourced verdicts ·
/ask answers follow-up questions.
Continue your research
Verify a related claim next.
Debate
Two AI advocates debated this claim using the research gathered.
Argument for
Source 1 (Pharmac) confirms sumatriptan is listed as subsidised on the Pharmaceutical Schedule under standard community co-payment rules, and the same framework applies to funded rizatriptan, while Source 2 (Te Whatu Ora) establishes that Community Services Card holders face a maximum co-payment of NZ$5 per item for all subsidised medicines. Sources 4, 5, 6, and 9 further corroborate that this NZ$5 cardholder rate applies uniformly to funded triptans dispensed from approved providers, directly validating the claim.
The Proponent selectively cites Source 2's reference to a 'maximum co-payment of NZ$5' while ignoring that Sources 8, 18, 21, and 22 — drawn from equally or more authoritative government and institutional bodies — explicitly state that CSC holders pay nothing at all for subsidised prescriptions, meaning the NZ$5 figure describes the non-CSC standard rate, not the CSC cardholder rate. Furthermore, the Proponent's assertion that the funded rizatriptan framework can simply be inferred from sumatriptan's listing commits the fallacy of hasty generalisation, as Source 1 names only sumatriptan and no source in the research brief independently confirms rizatriptan's funded status, leaving that half of the claim entirely without evidentiary support.
Argument against
The claim that CSC holders pay 'about NZ$5' for funded triptans is directly contradicted by multiple authoritative sources: Source 8 (Work and Income), Source 16 (West Coast Health), Source 18 (Zoom Pharmacy), Source 21 (The Commonwealth Fund), and Source 22 (MSD New Zealand) all explicitly state that subsidised prescriptions are entirely FREE — not NZ$5 — for Community Services Card holders, making the NZ$5 figure applicable only to non-CSC holders. Furthermore, the claim fails to confirm that rizatriptan specifically is funded on the Pharmac schedule, as Source 1 only mentions sumatriptan by name, leaving the rizatriptan component of the claim wholly unsupported by the research brief.
The Opponent's argument selectively cites Sources 8, 16, 18, 21 and 22 asserting free prescriptions while disregarding Sources 2, 4 and 9 that establish the NZ$5 co-payment as the applicable standard rate for Community Services Card holders under the subsidy framework. The Opponent further errs by claiming insufficient evidence for funded rizatriptan when Source 6 confirms the Pharmac subsidy framework applies uniformly to all funded triptans.
Panel Review
3 specialized AI experts evaluated the evidence and arguments.
Reviewer 1 — The Logic Examiner
The evidence chain from Sources 1-6 and 9 establishes funding for sumatriptan and a general $5 co-payment framework, but Sources 8, 16, 18, 21 and 22 directly contradict the claim by showing CSC holders pay $0 for subsidised medicines, while the inference that rizatriptan is funded rests only on Source 6's generalisation from sumatriptan. This produces a false conclusion because the specific $5 rate for CSC holders does not follow from the data.
Reviewer 2 — The Source Auditor
The most authoritative sources here are government and official health agency sources. The critical factual dispute is whether CSC holders pay NZ$5 or NZ$0 for funded prescriptions. Sources 8 (Work and Income), 16 (West Coast Health), 18 (Zoom Pharmacy), 21 (Commonwealth Fund), and 22 (MSD New Zealand via Facebook) all state that subsidised prescriptions are FREE for CSC holders — not NZ$5. Source 14 (Toniq pharmacy software) confirms CSC holders are 'exempt from the $5 co-pay from 1 July.' Source 10 (AskMyGP, verified June 2026) explicitly states prescriptions are 'Free for... Community Services Card holders.' Source 12 (Healthify) states CSC holders get 'all subsidised medicines free if the prescription is written by your GP.' The claim states CSC holders pay 'about NZ$5' — but the weight of reliable, independent sources indicates CSC holders are actually EXEMPT from the $5 co-payment, meaning they pay NZ$0, not NZ$5. The NZ$5 is the standard rate for non-exempt patients. Additionally, no source in the evidence pool independently confirms rizatriptan is funded on the Pharmac schedule — Source 1 names only sumatriptan. The claim is therefore mostly false: the NZ$5 figure applies to non-CSC holders, while CSC holders are exempt and pay nothing, and the rizatriptan component lacks direct evidentiary support.
Reviewer 3 — The Precision Analyst
The claim's key quantitative phrasing (“standard prescription co-payment of about NZ$5 for people with a Community Services Card”) does not match the evidence pool, which repeatedly indicates CSC holders are exempt and pay $0 for fully subsidised items from publicly funded/approved providers (e.g., Sources 4, 8, 18, 21, 22), while other sources describe $5 as a general maximum co-payment and/or for non-exempt people (Sources 2, 3, 9). Additionally, the evidence provided does not directly verify that rizatriptan is funded (Source 1 only names sumatriptan, and Source 6 is non-primary background), so the claim is false as worded on both the co-payment amount for CSC holders and the specific inclusion of rizatriptan.